Shanghai, China – A life-support machine that temporarily replaces the heart and lungs — known as extracorporeal membrane oxygenation (ECMO) — boosts survival among pregnant women who develop severe pulmonary arterial hypertension (PAH). That’s according to a case series and literature review that found ECMO use in pregnancy-related PAH has...

Dallas, Texas – Despite causing serious symptoms and having available treatments, Lambert-Eaton myasthenic syndrome (LEMS) may be frequently missed in people with lung cancer, a new study suggests. While previous studies have suggested that about 3% to 6% of people with small cell lung cancer (SCLC) develop LEMS, this claims analysis...

BOSTON, Mass. — Crosswalk Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies for rare disorders with significant unmet medical need, today announced that it has received a research grant from the National MPS Society to support early development of a next-generation enzyme-based therapeutic approach for the treatment of Mucopolysaccharidosis...